Fig. 7From: Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activityAnalysis of open field test NPs treatment prior (0–30 min) and post (30–60 min) amphetamine IP uptake using ANOVA. Recorded tracking of amphetamine-induced hyperactivity screening model during 60 min session of distance travelled (a), time mobile (b) and center time (c). Occupancy heat maps and plots produced by the ANY-maze software (d1-2–i1-2)Back to article page